Biocon Chief Kiran Mazumdar Shaw, husband donate over Rs 51 crore to University of Glasgow Medical Dialogues Bureau13 July 2019 12:55 PM ISTA further donation of USD 2.5 million will go towards creating a new Professorial Chair to be named the Mazumdar-Shaw Chair of Precision Oncology....
Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer Medical Dialogues Bureau10 July 2019 10:00 AM ISTLupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec...
Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene Medical Dialogues Bureau26 Jun 2019 9:00 AM ISTBristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
Roche wins Japan approval for personalised cancer drug Rozlytrek Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTZURICH: Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalised...
GSK forms drug discovery alliance with University of California CRISPR researchers Medical Dialogues Bureau14 Jun 2019 12:24 PM ISTBritish drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of...
Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer Medical Dialogues Bureau12 Jun 2019 9:50 AM ISTThe approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit Medical Dialogues Bureau12 Jun 2019 9:30 AM ISTRoche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
Roche gets USFDA nod for combo lymphoma treatment Polivy Medical Dialogues Bureau11 Jun 2019 9:30 AM ISTPolivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care Medical Dialogues Bureau3 Jun 2019 9:45 AM ISTThe new version of NAVIFY Tumor Board is initially available in the United States and Canada with additional markets to follow in the near future.New...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 5:12 PM ISTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
Novartis wins USFDA approval for first PI3K inhibitor for breast cancer Farhat Nasim27 May 2019 6:10 PM ISTThe drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin Farhat Nasim23 May 2019 11:59 AM ISTOgivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...
